Law360, New York (June 12, 2012, 3:10 PM ET) -- Seeking to undo a $1.2 million verdict related to bone drugs Aredia and Zometa, Novartis Pharmaceuticals Corp. told the Fourth Circuit on Friday that a lower court erred when deciding what evidence to allow in a case that’s part of vast multidistrict litigation.
A North Carolina judge awarded the damages two years ago after jurors found the company failed to warn a woman's doctor the medicines could cause a severe jaw disease known as osteonecrosis.
Novartis contends a new trial is warranted because of various alleged...
Novartis Asks 4th Circ. To Block $1M Aredia, Zometa Verdict
To view the full article, take a free trial now.
